Inhaler Revenue After Expiration of Primary Patents
For the 39 brand-name inhalers approved by FDA in 2000 through 2021, manufacturers earned $67.2 billion when primary patents were in effect, a study shows.
Michael Posey
January 4, 2023
For the 39 brand-name inhalers approved by FDA in 2000 through 2021, manufacturers earned $67.2 billion when primary patents were in effect, a study shows.
Rebates to the federal government for greater-than-inflation increases in the prices of Medicare Part B drugs would have totaled $3.7 billion had provisions of the
During 2017 through 2020, the cost of drugs reported as administered but discarded was $3.0 billion, according to an analysis of the Medicare Part B
Pharmacy benefits managers could find themselves in the crosshairs of Congress in coming months, the Wall Street Journal reports: “Targeting PBMs has increasingly become a
FDA issued warning letters to 5 firms for the unauthorized marketing of 15 different e-cigarette products that are packaged to look like toys, food, or
Medicare beneficiaries using insulin had the lowest total annual spending under the Part D Senior Savings Model when they were enrolled in model-participating Medicare Advantage
Two research studies, one in pharmacy and the other in medicine, address the challenge of managing care for the small number of patients who account
The WHO Model List of Essential Medicines has served as a template for national formularies since its first publication in 1977. It affects the diffusion
Instead of efficacy being positively correlated with price for oncology products approved for marketing in the U.S., a study of agents approved by the FDA
The medication portion of Medicare fee-for-service spending was relatively stable between 2008 and 2019, rising from 24.0% to 27.2% of all Medicare dollars, according to